Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinfeng Chen

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
Immunology and Cell Biology|December 22, 2018
The R132H mutation in IDH1 promotes the recruitment of NK cells through CX3CL1/CX3CR1 chemotaxis and is correlated with a better prognosis in gliomasFeifei Ren, Qitai Zhao, Lan Huang, et al.
Genome Biology|January 12, 2024
RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9Mengli Zhang, Judith Hyle, Xiaowen Chen, et al.
Science Immunology|January 19, 2020
Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndromeYuying Liu, Yiliang Fang, Xinfeng Chen, et al.
International Journal of Clinical and Experimental Pathology|June 23, 2015
Combined cancer testis antigens enhanced prediction accuracy for prognosis of patients with hepatocellular carcinomaMeng Wang, Jiansheng Li, Liping Wang, et al.
Medical Physics|February 12, 2021
Machine QA for the Elekta Unity system: A Report from the Elekta MR-linac consortiumDavid A Roberts, Carlos Sandin, Panu T Vesanen, et al.
Oncotarget|November 22, 2017
miR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinomaXiao Wang, Shasha Liu, Ling Cao, et al.
Nature Cell Biology|December 13, 2017
A Pck1-directed glycogen metabolic program regulates formation and maintenance of memory CD8<sup>+</sup> T cellsRuihua Ma, Tiantian Ji, Huafeng Zhang, et al.
Cancer Immunology, Immunotherapy : CII|January 17, 2024
Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignanciesXinfeng Chen, Binghe Tan, Haizhou Xing, et al.
Oncoimmunology|July 7, 2017
CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancerJieyao Li, Liping Wang, Xinfeng Chen, et al.
Immunotherapy|June 26, 2020
A Phase I clinical trial of chimeric antigen receptor-modified T cells in patients with relapsed and refractory lymphomaXinfeng Chen, Xin Li, Yanfen Liu, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Immunology and Cell Biology|December 22, 2018
The R132H mutation in IDH1 promotes the recruitment of NK cells through CX3CL1/CX3CR1 chemotaxis and is correlated with a better prognosis in gliomasFeifei Ren, Qitai Zhao, Lan Huang, et al.
Genome Biology|January 12, 2024
RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9Mengli Zhang, Judith Hyle, Xiaowen Chen, et al.
Science Immunology|January 19, 2020
Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndromeYuying Liu, Yiliang Fang, Xinfeng Chen, et al.
International Journal of Clinical and Experimental Pathology|June 23, 2015
Combined cancer testis antigens enhanced prediction accuracy for prognosis of patients with hepatocellular carcinomaMeng Wang, Jiansheng Li, Liping Wang, et al.
Medical Physics|February 12, 2021
Machine QA for the Elekta Unity system: A Report from the Elekta MR-linac consortiumDavid A Roberts, Carlos Sandin, Panu T Vesanen, et al.
Oncotarget|November 22, 2017
miR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinomaXiao Wang, Shasha Liu, Ling Cao, et al.
Nature Cell Biology|December 13, 2017
A Pck1-directed glycogen metabolic program regulates formation and maintenance of memory CD8<sup>+</sup> T cellsRuihua Ma, Tiantian Ji, Huafeng Zhang, et al.
Cancer Immunology, Immunotherapy : CII|January 17, 2024
Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignanciesXinfeng Chen, Binghe Tan, Haizhou Xing, et al.
Oncoimmunology|July 7, 2017
CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancerJieyao Li, Liping Wang, Xinfeng Chen, et al.
Immunotherapy|June 26, 2020
A Phase I clinical trial of chimeric antigen receptor-modified T cells in patients with relapsed and refractory lymphomaXinfeng Chen, Xin Li, Yanfen Liu, et al.
Pageof 14